The expression of SIRT1 regulates the metastaticplasticity of chondrosarcoma cells by inducing epithelial-mesenchymal transition
H Feng, J Wang, J Xu, C Xie, F Gao, Z Li - Scientific Reports, 2017 - nature.com
SIRT1 belongs to the mammalian sirtuin family and plays an important role in deacetylating
histone and nonhistone proteins. It is reported that SIRT1 is associated with tumor …
histone and nonhistone proteins. It is reported that SIRT1 is associated with tumor …
Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma
C Hao, PX Zhu, X Yang, ZP Han, JH Jiang, C Zong… - BMC cancer, 2014 - Springer
Background SIRT1 is a member of the mammalian sirtuin family with the ability to
deacetylate histone and nonhistone proteins. The correlation between SIRT1 expression …
deacetylate histone and nonhistone proteins. The correlation between SIRT1 expression …
[HTML][HTML] SIRT1 expression regulates the transformation of resistant esophageal cancer cells via the epithelial-mesenchymal transition
T Qin, W Liu, J Huo, L Li, X Zhang, X Shi, J Zhou… - Biomedicine & …, 2018 - Elsevier
Abstract Sirtuin1 (SIRT1) belongs to the mammalian sirtuin family and plays an important
role in deacetylating histones and non-histones. SIRT1 is associated with tumor metastasis …
role in deacetylating histones and non-histones. SIRT1 is associated with tumor metastasis …
[HTML][HTML] SIRT1 promotes metastasis of human osteosarcoma cells
Pulmonary metastasis is the leading cause of mortality in patients with osteosarcoma;
however, the underlying mechanism remains unclear. The NAD+-dependent deacetylase …
however, the underlying mechanism remains unclear. The NAD+-dependent deacetylase …
SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells
T Sun, L Jiao, Y Wang, Y Yu, L Ming - Cell death & disease, 2018 - nature.com
Melanoma is highly metastatic, and understanding of its molecular mechanism is urgently
needed for the development of therapeutic targets and prognostic assessment for metastatic …
needed for the development of therapeutic targets and prognostic assessment for metastatic …
[HTML][HTML] SIRT6 inhibits proliferation and invasion in osteosarcoma cells by targeting N‑cadherin
Y Gao, Y Qu, Q Zhou, Y Ma - Oncology Letters, 2019 - spandidos-publications.com
SIRT6, is a member of the NAD‑dependent sirtuin family of enzymes, and has been reported
as a novel tumor suppressor gene or oncogene, dependent on the type of cancer. However …
as a novel tumor suppressor gene or oncogene, dependent on the type of cancer. However …
SIRT2 promotes the viability, invasion and metastasis of osteosarcoma cells by inhibiting the degradation of Snail
Y Tian, R Liu, X Hou, Z Gao, X Liu, W Zhang - Cell Death & Disease, 2022 - nature.com
Osteosarcomas (OS) are highly metastatic and usually lead to poor outcomes. Epithelial-
mesenchymal transition (EMT) is reported to be a critical event in metastasis. SIRT2 exerts …
mesenchymal transition (EMT) is reported to be a critical event in metastasis. SIRT2 exerts …
SIRT1‐ZEB1‐positive feedback promotes epithelial‐mesenchymal transition process and metastasis of osteosarcoma
XJ Yu, XZ Guo, C Li, Y Chong, TN Song… - Journal of Cellular …, 2019 - Wiley Online Library
Osteosarcoma is the most common malignant bone cancer that mainly affects children and
young adults. Recently, the NAD+‐dependent deacetylase, sirtuin 1 (SIRT1), has been …
young adults. Recently, the NAD+‐dependent deacetylase, sirtuin 1 (SIRT1), has been …
Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial–mesenchymal transition in cancer cells
J Choupani, S Mansoori Derakhshan… - Journal of cellular …, 2018 - Wiley Online Library
The epithelial–mesenchymal transition (EMT) is a highly networked cellular process which
involves cell transition from the immotile epithelial to the motile mesenchymal phenotype …
involves cell transition from the immotile epithelial to the motile mesenchymal phenotype …
Down-regulation of SIRT3 promotes ovarian carcinoma metastasis
X Dong, L Jing, W Wang, Y Gao - Biochemical and biophysical research …, 2016 - Elsevier
Distant metastasis and local recurrence are still the major causes for failure of treatment in
patients with ovarian carcinoma (OC), making it urgent to further elicit the molecular …
patients with ovarian carcinoma (OC), making it urgent to further elicit the molecular …